The FDA has not responded to a petition filed earlier this year by the consumer advocacy group Public Citizen for an Xenical recall and Alli recall to be issued for the weight-loss drugs, which have been linked to an increased risk of liver failure, liver damage, pancreatitis and kidney failure. The Xenical and Alli lawyers at Saiontz & Kirk, P.A. represent individuals throughout the United States who have experienced these side effects, and urge the FDA to remove the orlistat medications from the market.
The prescription drug Xenical and a lower dose over-the-counter version sold as Alli both contain the active pharmaceutical ingredient orlistat, which is designed to promote weight loss when taken together with a reduced calorie low-fat diet. However, the minimal weight-loss benefits are substantially outweighed by the risk of serious and potentially life-threatening side effects of Alli and Xenical.
On April 14, 2011, Public Citizen filed a petition for the FDA to recall Alli and Xenical by banning the use of orlistat. This was actually Public Citizen’s second petition for the FDA to recall Xenical, after the FDA rejected a prior petition to remove Xenical from the market in 2006.
The FDA indicated in August 2009 that they were reviewing the potential risk of liver damage from Alli and Xenical. At that time, the agency indicated that they were aware of at least 32 reports of serious liver injury with orlistat between 1999 and October 2008, including at least 6 reports of liver failure and 27 cases that resulted in hospitalization
In April 2011, a study published in the Archives of Internal Medicine, which examined data on nearly 1,000 users of Xenical in Canada, found that about 1 in 50 users of the weight-loss drug could expect to be hospitalized for kidney problems. While researchers found that approximately 2% of users were hospitalized for kidney damage on Xenical, that compares with only about 0.5% for the rest of the population.
According to a recent analysis by Public Citizen of adverse event reports submitted to the FDA, there have also been 47 cases of acute pancreatitis and 73 cases of kidney stones, as well as at least 12 reports of severe liver injury from outside the United States.
Last month, the European Medicines Agency (EMA) indicated that a review of the risk-benefits analysis for Xenical and Alli has been launched to evaluate the risk of liver injury. If the EMA concludes that the risks outweigh the benefits, Alli and Xenical could be recalled across Europe.
XENICAL AND ALLI LAWSUITS
The lawyers at Saiontz & Kirk, P.A. are continuing to review potential claims for individuals who may be entitled to compensation through an Xenical lawsuit or Alli lawsuit after suffering any of the following potential side effects:
- Liver Damage
- Liver Failure
- Kidney Failure
To review a potential case for yourself, a friend or family member for health problems caused by Alli or Xenical, request a free consultation and claim evaluation.